A Phase II Study of Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy.
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin; Gemcitabine
- Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer; Liver cancer
- Focus Therapeutic Use
- 12 Mar 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Apr 2013 Planned end date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 18 Apr 2012 Planned end date changed from 1 Jun 2011 to 1 Jun 2013 as reported by ClinicalTrials.gov.